Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03899792
Title	A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors (LIBRETTO-121)
Acronym	LIBRETTO-121
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Loxo Oncology, Inc.
Indications	central nervous system cancer Advanced Solid Tumor
Therapies	Selpercatinib
Age Groups:	adult \| child
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| DNK \| DEU \| CAN \| AUS